Figure 1. Comparison of survival in patients younger than and older than 50 years old who were diagnosed with exocrine pancreatic tumors (solid line: patients ≤ 50 years old; dashed line: patients > 50 years old).
| World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access |
| Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc |
| Journal website http://www.wjon.org |
Original Article
Volume 5, Number 1, February 2014, pages 7-13
Age Influences Likelihood of Pancreatic Cancer Treatment, but not Outcome
Figures
Tables
| Age ≤ 50 years (%), N = 53 | Age > 50 years (%), N = 254 | P value | |
|---|---|---|---|
| Age | 44 ± 5.7 | 67.2 ± 9.3 | < 0.001 |
| Gender | |||
| Male | 33 (64) | 143 (57) | 0.372 |
| Female | 19 (37) | 109 (43) | |
| Race | |||
| Caucasian | 34 (92) | 158 (93) | 0.585 |
| African American | 3 (8) | 9 (5) | |
| Other | 0 (0) | 3 (2) | |
| Location of tumor (%) | 0.541 | ||
| Head of pancreas | 34( 63) | 146 (58) | |
| Body/tail of pancreas | 12 (23) | 59 (23) | |
| Unknown | 7 (13) | 49 (19) | |
| Exocrine tumor stage | 0.516 | ||
| I | 3 (8) | 16 (7) | |
| II | 12 (30) | 53 (25) | |
| III | 8 (20) | 24 (11) | |
| IV | 17 (42) | 123 (57) |
| Age ≤ 50 (%) | Age > 50 (%) | P value | |
|---|---|---|---|
| Surgery | 11 (22) | 51 (20) | 0.911 |
| Chemotherapy | 33 (62) | 104 (41) | 0.005 |
| Radiation | 15 (28) | 39 (15) | 0.025 |
| Number still alive | 4 (8) | 19 (8) | 0.987 |
| Overall survival (months) | 24.2 | 14 | 0.06 |
| Patient population | ≤ 50 years (%) | > 50 years (%) | P value |
|---|---|---|---|
| Exocrine | 41 (15) | 237 (85) | |
| Endocrine | 12 (41) | 17 (59) | |
| Age | |||
| Exocrine | 45 ± 4.7 | 67.4 ± 9.3 | < 0.001 |
| Endocrine | 40.7 ± 7.6 | 64 ± 8.2 | < 0.001 |
| Location of tumor | |||
| Exocrine | 0.24 | ||
| Head of pancreas | 30 (73) | 142 (60) | |
| Body/tail of pancreas | 7 (17) | 51 (21) | |
| Unknown | 4 (10) | 44 (19) | |
| Endocrine | 0.84 | ||
| Head of pancreas | 4 (33) | 4 (24) | |
| Body/tail of pancreas | 5 (39) | 8 (47) | |
| Unknown | 3 (38) | 5 (29) | |
| Surgery performed | |||
| Exocrine | 7 (17) | 41 (17) | 0.97 |
| Endocrine | 4 (33) | 10 (59) | 0.23 |
| Chemotherapy | |||
| Exocrine | 28 (68) | 98 (42) | 0.001 |
| Endocrine | 5 (42) | 6 (35) | 0.73 |
| Radiation therapy | |||
| Exocrine | 15 (37) | 39 (17) | 0.003 |
| Endocrine | 0 | 0 | |
| Number still alive | |||
| Exocrine | 0 (0) | 11 (5) | 0.16 |
| Endocrine | 4 (33) | 8 (47) | 0.46 |
| Overall survival (months) | |||
| Exocrine | 9.6 | 11.2 | 0.64 |
| Endocrine | 74.3 | 47.6 | 0.19 |